Efficacy of tonsillectomy in treatment of recurrent group A beta-hemolytic streptococcal pharyngitis

Laura J Orvidas1, Jennifer L St Sauver, Amy L Weaver

  • 1Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota 55905, USA. orvidas.laura@mayo.edu

The Laryngoscope
|November 1, 2006
PubMed

Insights

Tonsillectomy significantly reduces recurrent group A beta-hemolytic streptococcal (GABHS) infections in children. Surgery also increases the time before subsequent GABHS pharyngitis develops, offering long-term protection.

Area of Science:

  • Pediatric infectious diseases
  • Otolaryngology

Background:

  • Recurrent group A beta-hemolytic streptococcal (GABHS) pharyngitis poses a significant health burden in children.
  • Tonsillectomy is a common surgical intervention for recurrent pharyngitis, but its efficacy in reducing GABHS infections requires further investigation.

Purpose of the Study:

  • To evaluate the effectiveness of tonsillectomy in preventing recurrent group A beta-hemolytic streptococcal (GABHS) infections in children.
  • To compare the incidence and timing of subsequent GABHS infections in children who underwent tonsillectomy versus those who did not.

Main Methods:

  • Retrospective cohort study involving 290 children aged 4 to <16 years.
  • Inclusion criteria: three or more GABHS pharyngitis episodes within 12 months, at least one month apart.
  • Statistical analysis adjusted for prior infection history and pre-existing conditions.

Main Results:

  • Children without tonsillectomy were 3.1 times more likely to develop subsequent GABHS pharyngitis.
  • The median time to subsequent infection was shorter for non-tonsillectomy patients (0.6 years) compared to tonsillectomy patients (1.1 years).
  • Adjusted analyses confirmed the protective effect of tonsillectomy against recurrent GABHS infections.

Conclusions:

  • Tonsillectomy is associated with a significant decrease in the number of GABHS infections in children with a history of recurrent infections.
  • The surgical procedure also extends the interval before the development of further GABHS pharyngitis.
  • Tonsillectomy represents an effective strategy for managing recurrent GABHS infections in pediatric patients.
Abstract

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...